This is the authors' abstract. We don't add key points for this paper.
The findings of this cohort study suggest that there is no association between prenatal exposure to ASMs and allergic diseases in offspring. However, infant exposure to ASMs was associated with a higher risk of developing asthma, although the magnitude was more modest than previously reported. Clinicians should carefully weigh the benefits of prescribing ASMs to children, accompanied by subsequent close monitoring for any clinically relevant safety signals.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Noh et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: